Skip to main content
Premium Trial:

Request an Annual Quote

Pall Acquires Euroflow; Second Chromatography Purchase in Two Months

NEW YORK, Jan. 25 (GenomeWeb News) - Pall said today that it has acquired Euroflow, a Stroud, UK-based manufacturer of chromatography columns for the biotechnology industry.


Pall has held exclusive global marketing and distribution rights to Euroflow's chromatography columns and associated technologies since 2002.


A Pall spokeswoman declined to reveal the financial terms of the acquisition, noting that Euroflow's small size makes the purchase price "immaterial."


Pall said that Euroflow's sales are currently about $5 million a year.


The acquisition follows upon Pall's purchase of the BioSepra Process Division from Ciphergen Biosystems for $32 million, which closed last month.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.